Hepion Pharmaceuticals - 53 Year Dividend History | HEPA
Historical dividend payout and yield for Hepion Pharmaceuticals (HEPA) since 1971. The current TTM dividend payout for Hepion Pharmaceuticals (HEPA) as of December 20, 2024 is $0.00. The current dividend yield for Hepion Pharmaceuticals as of December 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.004B |
$0.000B |
|
Hepion Pharmaceuticals Inc. is a clinical stage biopharmaceutical company. It is focused on the development of targeted therapies for liver disease arising from non-alcoholic steatohepatitis and chronic hepatitis virus infection. The Company's lead drug candidate CRV431, reduces liver fibrosis and hepatocellular carcinoma tumor burden in experimental models of NASH. Hepion Pharmaceuticals Inc., formerly known as ContraVir Pharmaceuticals Inc., is based in Edison, New Jersey.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
